Inactive Instrument
Argos Therapeutics Inc Share Price Nasdaq
Stocks
US0402212023
Pharmaceuticals
OTC Markets Traded| Market Cap | 318K 279K 259K 239K 447K 30.67M 456K 3.09M 1.21M 14.98M 1.19M 1.17M 52.04M | P/E 2016 |
-2.96x | P/E 2017 | -0.22x |
|---|---|---|---|---|---|
| Enterprise Value | 4.58M 4.03M 3.74M 3.44M 6.46M 443M 6.58M 44.65M 17.44M 216M 17.21M 16.84M 751M | EV / Sales 2016 |
200x | EV / Sales 2017 | 9.19x |
| Free-Float |
88.73% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | -4.99% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.99% | -75.88% | - | - | 567K | |
| +0.11% | -1.89% | +16.22% | -11.26% | 66.25B | |
| -0.12% | +3.10% | +40.83% | +196.27% | 52.86B | |
| +0.51% | +37.90% | +37.90% | +37.90% | 43.01B | |
| -1.86% | -4.93% | -56.15% | -56.66% | 39.52B | |
| +1.46% | +1.71% | +56.92% | -27.51% | 29.19B | |
| +0.78% | +1.39% | +69.36% | +81.90% | 23.13B | |
| -1.81% | -16.49% | +74.21% | -54.90% | 23.04B | |
| -1.30% | -6.18% | +3.94% | +177.59% | 20.48B | |
| -1.04% | +0.53% | +69.40% | +119.96% | 16.6B | |
| Average | -0.69% | -2.11% | +34.74% | +51.48% | 34.9B | |
| Weighted average by Cap. | -0.14% | -1.59% | +28.19% | +46.09% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 945K 831K 772K 710K 1.33M 91.3M 1.36M 9.21M 3.6M 44.58M 3.55M 3.47M 155M | 1.9M 1.67M 1.55M 1.43M 2.67M 183M 2.73M 18.5M 7.22M 89.57M 7.13M 6.98M 311M |
| Net income | -53.03M -46.61M -43.31M -39.83M -74.68M -5.12B -76.11M -516M -202M -2.5B -199M -195M -8.69B | -40.58M -35.67M -33.14M -30.48M -57.15M -3.92B -58.24M -395M -154M -1.91B -152M -149M -6.65B |
| Net Debt | -13.11M -11.52M -10.71M -9.85M -18.46M -1.27B -18.81M -128M -49.86M -618M -49.2M -48.15M -2.15B | 4.27M 3.75M 3.49M 3.21M 6.01M 412M 6.12M 41.56M 16.23M 201M 16.02M 15.67M 699M |
Employees
-
Sector
Pharmaceuticals
